ZTSZoetis Inc.Large cap · $31.61B · FY ending 2025-12-31
$75.39-0.22% · 2026-07-13 · EOD
69/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality78
margins & F-ScoreValue88
P/E 12.5 · 4% of 12-mo rangeMomentum22
death · price below 200-daySmart Money88
buying · 2 funds · 3P/0S insidersBearish stackDeath crossBelow 200-day
vs S&P 500-49.2%
6-mo excess Trailing performance1M -7.3%
3M -36.0%
6M -40.6%
YTD -40.1%
1Y -52.5%
P/E vs its last 12 months (our price history): 11.9 low → 26.0 high
Current price sits at the 4th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Piotroski F5/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 20%. Annual figures from SEC XBRL.
Dividend & capital return
Shareholder yield10.2%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying3P / 0S insiders · 2 funds hold · 1 Congress buys
Recent insidersBisaro Paul · DirectorBUY$151,750
DAMELIO FRANK A · DirectorBUY$501,344
MCCALLISTER MICHAEL B · DirectorBUY$233,273
Fund holders (13F)Polen Capital$499.2M3.5% of book
Fundsmith (Terry Smith)$458.4M3.6% of book
Chealth · 58/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.